Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples